Miyagi Taeko | Division of Cancer Glycosylation Research, Institute of Molecular Biomembrane and Glycobiology, Toho
スポンサーリンク
概要
- 同名の論文著者
- Division of Cancer Glycosylation Research, Institute of Molecular Biomembrane and Glycobiology, Tohoの論文著者
関連著者
-
Miyagi Taeko
Division of Cancer Glycosylation Research, Institute of Molecular Biomembrane and Glycobiology, Toho
-
YAMAGUCHI Kazunori
Division of Biochemistry, Miyagi Cancer Center Research Institute
-
SHIOZAKI Kazuhiro
Division of Biochemistry, Miyagi Cancer Center Research Institute
-
Miyagi Taeko
Division Of Biochemistry Miyagi Cancer Center Research Institute
-
Yamaguchi Kazunori
Division Of Biochemistry Miyagi Cancer Center Research Institute
-
Shiozaki Kazuhiro
Division Of Biochemistry Miyagi Cancer Center Research Institute
-
Wada Tadashi
Division Of Biochemistry Miyagi Cancer Center Research Institute
-
KAKUGAWA Yoichiro
Department of Surgery, Montreal General Hospital
-
Kakugawa Yoichiro
Department Of Surgery Miyagi Cancer Center
-
HATA Keiko
Division of Biochemistry, Miyagi Cancer Center Research Institute
-
YAMANAMI Hideaki
Division of Biochemistry, Miyagi Cancer Center Research Institute
-
UEMURA Takuji
Division of Biochemistry, Miyagi Cancer Center Research Institute
-
HUJIYA Tsuneaki
Department of Surgery, Miyagi Cancer Center
-
Hata Keiko
Division Of Biochemistry Miyagi Cancer Center Research Institute
-
Yamanami Hideaki
Division Of Biochemistry Miyagi Cancer Center Research Institute
-
Uemura Takuji
Division Of Biochemistry Miyagi Cancer Center Research Institute
-
SATO Ikuro
Division of Pathology, Miyagi Cancer Center Research Institute
-
Sato Ikuro
Division Of Pathology Miyagi Cancer Center Research Institute
-
Hujiya Tsuneaki
Department Of Surgery Miyagi Cancer Center
著作論文
- シアリダーゼとその機能
- Plasma Membrane-associated Sialidase as a Crucial Regulator of Transmembrane Signalling
- Down-regulation of sialidase NEU4 may contribute to invasive properties of human colon cancers
- Plasma membrane-associated sialidase (NEU3) promotes formation of colonic aberrant crypt foci in azoxymethane-treated transgenic mice